Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4+ T cell activation and HIV-1 latency reversal
Sign Up to like & getrecommendations! Published in 2019 at "Science Advances"
DOI: 10.1126/sciadv.aav6322
Abstract: Targeted nanocarriers deliver HIV-1 latency-reversing agents to CD4+ T cells in the lymph nodes. A proposed strategy to cure HIV uses latency-reversing agents (LRAs) to reactivate latent proviruses for purging HIV reservoirs. A variety of… read more here.
Keywords: cd4 cells; latency; hiv; hybrid nanocarriers ... See more keywords